NM_000548.5:c.4107G>A

Variant names:

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2

The NM_000548.5(TSC2):c.4107G>A(p.Arg1369Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000026 in 1,612,694 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. R1369R) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000039 ( 0 hom., cov: 33)

Exomes 𝑓: 0.000025 ( 0 hom. )

Consequence

TSC2
NM_000548.5 synonymous

Scores

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 1.17

Publications

2 publications found

Variant links:

Genes affected

TSC2 (HGNC:12363): (TSC complex subunit 2) This gene is a tumor suppressor gene that encodes the growth inhibitory protein tuberin. Tuberin interacts with hamartin to form the TSC protein complex which functions in the control of cell growth. This TSC protein complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]

TSC2 Gene-Disease associations (from GenCC):

tuberous sclerosis
Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
tuberous sclerosis 2
Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Ambry Genetics
lymphangioleiomyomatosis
Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
tuberous sclerosis complex
Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

TSC2 links:

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

BP4

Computational evidence support a benign effect (BayesDel_noAF=-0.46).

BP6

Variant 16-2084329-G-A is Benign according to our data. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2084329-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 207681.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

BP7

Synonymous conserved (PhyloP=1.17 with no splicing effect.

BS2

High AC in GnomAd4 at 6 AD gene.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
TSC2	NM_000548.5 link	c.4107G>A	p.Arg1369Arg	synonymous_variant	Exon 34 of 42	ENST00000219476.9	NP_000539.2	P49815-1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
TSC2	ENST00000219476.9 link	c.4107G>A	p.Arg1369Arg	synonymous_variant	Exon 34 of 42	5	NM_000548.5	ENSP00000219476.3		P49815-1

Frequencies

GnomAD3 genomes

AF:

0.0000329

AC:

AN:

152206

Hom.:

Cov.:

show subpopulations

Gnomad AFR

AF:

0.00

Gnomad AMI

AF:

0.00

Gnomad AMR

AF:

0.000131

Gnomad ASJ

AF:

0.00

Gnomad EAS

AF:

0.00

Gnomad SAS

AF:

0.00

Gnomad FIN

AF:

0.00

Gnomad MID

AF:

0.00

Gnomad NFE

AF:

0.0000441

Gnomad OTH

AF:

0.00

GnomAD2 exomes

AF:

0.0000322

AC:

AN:

248684

AF XY:

0.0000370

show subpopulations

Gnomad AFR exome

AF:

0.0000624

Gnomad AMR exome

AF:

0.000145

Gnomad ASJ exome

AF:

0.00

Gnomad EAS exome

AF:

0.00

Gnomad FIN exome

AF:

0.00

Gnomad NFE exome

AF:

0.00000895

Gnomad OTH exome

AF:

0.000165

GnomAD4 exome

AF:

0.0000247

AC:

AN:

1460370

Hom.:

Cov.:

AF XY:

0.0000220

AC XY:

AN XY:

726476

show subpopulations

African (AFR)

AF:

0.000149

AC:

AN:

33480

American (AMR)

AF:

0.000157

AC:

AN:

44708

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

26136

East Asian (EAS)

AF:

0.00

AC:

AN:

39700

South Asian (SAS)

AF:

0.00

AC:

AN:

86242

European-Finnish (FIN)

AF:

0.00

AC:

AN:

51996

Middle Eastern (MID)

AF:

0.000173

AC:

AN:

5768

European-Non Finnish (NFE)

AF:

0.0000171

AC:

AN:

1111964

Other (OTH)

AF:

0.0000663

AC:

AN:

60376

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.489

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Exome Het

Variant carriers

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

GnomAD4 genome

AF:

0.0000394

AC:

AN:

152324

Hom.:

Cov.:

AF XY:

0.0000134

AC XY:

AN XY:

74482

show subpopulations

African (AFR)

AF:

0.0000241

AC:

AN:

41568

American (AMR)

AF:

0.000131

AC:

AN:

15310

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

3472

East Asian (EAS)

AF:

0.00

AC:

AN:

5180

South Asian (SAS)

AF:

0.00

AC:

AN:

4834

European-Finnish (FIN)

AF:

0.00

AC:

AN:

10632

Middle Eastern (MID)

AF:

0.00

AC:

AN:

294

European-Non Finnish (NFE)

AF:

0.0000441

AC:

AN:

68006

Other (OTH)

AF:

0.00

AC:

AN:

2116

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.465

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Genome Het

Variant carriers

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

Alfa

AF:

0.0000282

Hom.:

Bravo

AF:

0.0000302

Asia WGS

AF:

0.000289

AC:

AN:

3478

EpiCase

AF:

0.0000545

EpiControl

AF:

0.00

ClinVar

Significance: Benign/Likely benign

Submissions summary: Benign:9

Revision: criteria provided, multiple submitters, no conflicts

LINK: link

Submissions by phenotype

Tuberous sclerosis 2

Benign:4

Jul 07, 2023

KCCC/NGS Laboratory, Kuwait Cancer Control Center

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Nov 07, 2021

Genome-Nilou Lab

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Jan 30, 2025

Labcorp Genetics (formerly Invitae), Labcorp

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Jun 02, 2025

Myriad Genetics, Inc.

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. -

not specified

Benign:1

Nov 22, 2014

GeneDx

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Tuberous sclerosis syndrome

Benign:1

Feb 05, 2024

All of Us Research Program, National Institutes of Health

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

TSC2-related disorder

Benign:1

Jul 12, 2023

PreventionGenetics, part of Exact Sciences

Significance:Likely benign

Review Status:no assertion criteria provided

Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided

Benign:1

Oct 01, 2023

CeGaT Center for Human Genetics Tuebingen

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

TSC2: BP4, BP7 -

Hereditary cancer-predisposing syndrome

Benign:1

Apr 10, 2019

Ambry Genetics

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

BayesDel_noAF

Benign

-0.46

CADD

Benign

(source)

DANN

Benign

0.85

PhyloP100

1.2

RBP_binding_hub_radar

0.0

RBP_regulation_power_radar

1.7

Splicing

Name

Calibrated prediction

Score

Prediction

SpliceAI score (max)

0.14

Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

Publications

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

Age Distribution

Age Distribution

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

Other links and lift over